3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics
BUDAPEST, Hungary--(BUSINESS WIRE)--Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member…
BUDAPEST, Hungary--(BUSINESS WIRE)--Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member…
CHICAGO--(BUSINESS WIRE)--Strike, the world’s leading digital payments platform built on Bitcoin’s Lightning Network, today announced…
Distill hundreds of individual customer comments into an easy to understand short overview of the…
HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the…
DUBLIN--(BUSINESS WIRE)--The "Thailand: Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's…
Study reveals consumers will make purchasing decisions based on emotional connection and price relief through…
Software Compatibility with Other Renesas MPUs/MCUs Allows Developers to Seamlessly Implement Scalable Design TOKYO--(BUSINESS WIRE)--#Renesas--Renesas…
Phase 1 trial of OLX72021 has been approved for initiation in Australia OliX will evaluate…
DUBLIN--(BUSINESS WIRE)--The "The Philippines: Existing & Upcoming Data Center Portfolio" database has been added to…
EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in…